ALC

Alcon Inc.

$74.06

-1.44%
SectorHealthcareIndustryMedical Instruments & SuppliesCountrySwitzerland

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert.

Source: Yahoo Finance
AI summary

Price & performance

1M+21.3%
3M+8.9%
YTD+0.1%
1Y+4.7%
52-week range—
Beta0.67
Full chart and returns against a benchmark

Q-Score

60/ 100

Quality against peers; 50 is the peer median.

Growth51
Risk80
Performance45
Valuation58
Profitability62
Leverage57
Sentiment40
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$10.4B+4.9%
Net income$980M-3.7%
Net margin9.4%-0.8 pts
Historical fundamentals

Revenue exposure

55%of revenue from outside the US
United States45%
Other Countries43%
Japan6%
Regions, segments, customers and suppliers

Valuation

ALCIndustryP/E36.5349.36P/S3.443.73EV/EBITDA28.2623.12P/B1.623.92PEG——
Dividend yield0.46%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate$0.89
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate